CRDF
Cardiff Oncology Inc.
$2.07
+$0.02(+0.98%)
52
Overall
60
Value
45
Tech
--
Quality
Market Cap
$136.38M
Volume
648.28K
52W Range
$1.90 - $5.64
Target Price
$10.50
Order:
Income Statement
| Metric | Trend | Chart | 2014 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $280.2K | $381.1K | $505.4K | $250.5K | $243.1K | $366.0K | $359.0K | $386.0K | $488.0K | $683.0K | ||
| Total Revenue | $280.2K | $381.1K | $505.4K | $250.5K | $243.1K | $366.0K | $359.0K | $386.0K | $488.0K | $683.0K | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-15.4K | $-1.7M | $-1.8M | $-597.5K | -- | -- | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $264.7K | $-1.3M | $-1.3M | $-347.0K | $243.1K | $366.0K | $359.0K | $386.0K | $488.0K | $683.0K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-15.2M | $-40.5M | $-26.1M | $-17.4M | $-16.9M | $19.5M | $29.2M | $40.3M | $45.9M | $49.3M | ||
| Research & Development | $6.7M | $15.0M | $7.9M | $8.2M | $11.2M | $11.2M | $17.4M | $27.1M | $32.9M | $36.9M | ||
| Research Expense | $6.7M | $15.0M | $7.9M | $8.2M | $11.2M | $11.2M | $17.4M | $27.1M | $32.9M | $36.9M | ||
| Selling, General & Administrative | $8.5M | $23.0M | $14.2M | $8.0M | $5.8M | $8.2M | $11.8M | $13.2M | $13.0M | $12.5M | ||
| Selling & Marketing Expenses | $2.7M | $11.5M | $14.2M | $8.0M | $5.8M | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $5.8M | $11.5M | $-663.0K | $-731.0K | $-63.2K | $8.2M | $11.8M | $13.2M | $13.0M | $12.5M | ||
| Salaries & Wages | $-2.1M | -- | -- | $-2.2M | $-884.9K | -- | -- | -- | $4.5M | $4.8M | ||
| Depreciation & Amortization | $-234.8K | -- | -- | $-736.1K | $-494.2K | $500.0K | $500.0K | $200.0K | $400.0K | $400.0K | ||
| Depreciation & Amortization | $-234.8K | -- | -- | $-736.1K | $-494.2K | $500.0K | $500.0K | $200.0K | $400.0K | $400.0K | ||
| Other Operating Expenses | $-24.8K | $144.7K | $170.1K | $236.8K | $-2.0K | $441.0K | $745.0K | $754.0K | $714.0K | $667.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-14.9M | $-39.5M | $-23.6M | $-16.8M | $-16.7M | $-19.1M | $-28.9M | $-39.9M | $-45.4M | $-48.7M | ||
| EBITDA | $-13.0M | $-36.2M | $-22.5M | $-15.6M | $-15.9M | $-18.8M | $-28.4M | $-39.7M | $-50.1M | $-54.3M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $843.3K | $1.7M | $1.0M | $25.4K | -- | $2.0K | -- | -- | -- | -- | ||
| Intinc | -- | $298.8K | $147.9K | $219.4K | $234.2K | $90.0K | $264.0K | $1.6M | $4.1M | $3.3M | ||
| Net Non-Operating Interest Income/Expense | $-831.0K | $-1.4M | $-886.1K | $194.0K | $234.2K | $88.0K | $264.0K | $1.6M | $4.1M | $3.3M | ||
| Gain on Sale of Securities | $1.4M | $2.5M | $3.4M | $617.1K | $28.2K | $-281.0K | $285.0K | -- | -- | -- | ||
| Other Income/Expense | $-1.4M | $-2.5M | $-1.7M | $-762.9K | $-29.7K | $309.0K | $-300.0K | $-383.0K | $98.0K | $39.0K | ||
| Other Special Charges | -- | -- | $-1.7M | $145.8K | $1.5K | $-28.0K | $15.0K | $-383.0K | $-98.0K | $-39.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $790.4K | $2.2M | $664.7K | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | $-790.4K | $-2.2M | $-664.7K | -- | -- | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $-187.5K | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-13.5M | $-37.5M | $-23.9M | $-16.4M | $-16.4M | $-19.3M | $-28.9M | $-39.9M | $-50.5M | $-54.7M | ||
| Pre-Tax Income | $-14.3M | $-39.2M | $-24.9M | $-16.5M | $-16.4M | $-19.3M | $-28.3M | $-38.7M | $-41.4M | $-45.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-1.0K | -- | -- | $-1.0K | $-1.0K | $-4.1M | $-6.1M | $-518.0K | $-9.1M | $-9.3M | ||
| NET INCOME | ||||||||||||
| Net Income | $-14.3M | $-39.2M | $-24.9M | $-16.5M | $-16.4M | $-19.3M | $-28.3M | $-38.7M | $-41.4M | $-45.4M | ||
| Net Income (Continuing Operations) | $-14.3M | $-39.2M | $-24.9M | $-16.5M | $-16.4M | $-19.3M | $-28.3M | $-38.7M | $-41.4M | $-45.4M | ||
| Net Income (Discontinued Operations) | $-14.3M | $-39.2M | $-24.9M | $-16.5M | $-16.4M | $-19.3M | $-28.3M | $-38.7M | $-41.4M | $-45.4M | ||
| Net Income (Common Stockholders) | $-14.3M | $-39.2M | $-24.9M | $-19.3M | $-16.7M | $-22.6M | $-28.3M | $-38.7M | $-41.5M | $-45.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-34.4M | -- | -- | $-54.7M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-15.2M | $-42.3M | $-27.9M | $-18.0M | $-16.9M | $19.5M | $29.2M | $40.3M | $45.9M | $49.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $3.2M | $5.0M | $5.8M | $388.4K | $6.0M | $20.9M | $39.0M | $43.6M | $44.7M | $47.6M | ||
| Average Shares Outstanding (Diluted) | $3.2M | $5.0M | $5.8M | $388.4K | $5.9M | $20.9M | $39.0M | $43.6M | $44.7M | $47.6M | ||
| Shares Outstanding | $335.1K | $430.1K | $767.9K | $670.3K | $10.2M | $37.1M | $43.3M | $44.7M | $44.7M | $66.5M | ||
| Basic EPS | $-4.56 | $-7.8 | $-4.32 | $-49.56 | -- | $-1.08 | $-0.73 | $-0.89 | $-0.93 | $-0.95 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-1.08 | $-0.73 | $-0.89 | $-0.93 | $-0.95 | ||
| Diluted EPS | $-5.28 | $-8.22 | $-4.32 | $-49.56 | $-2.8 | $-1.08 | $-0.73 | $-0.89 | $-0.93 | $-0.95 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-0.73 | $-0.89 | $-0.93 | $-0.95 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | $23.0K | $24.2K | $24.2K | $2.8M | $292.5K | $3.3M | $24.0K | $24.0K | $24.0K | $24.0K | ||
| Gain On Sale Of P P E | $24.8K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | -- | $-1.4M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $5.8M | $11.5M | $-663.0K | $-731.0K | $-63.2K | $8.2M | $11.8M | $13.2M | $13.0M | $12.5M | ||
| Otherunder Preferred Stock Dividend | $23.0K | $24.2K | $24.2K | $2.8M | $292.5K | $3.3M | $24.0K | $24.0K | $24.0K | $24.0K | ||
| Preferred Stock Dividends | $23.0K | $24.2K | $24.2K | $2.8M | $292.5K | $3.3M | $24.0K | $24.0K | $24.0K | $24.0K | ||
| Rent And Landing Fees | $5.8M | $11.5M | $-663.0K | $-731.0K | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $2.7M | $11.5M | $14.2M | $8.0M | $5.8M | -- | -- | -- | -- | -- | ||
| Restruct | -- | $790.4K | $2.2M | $664.7K | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDF | $2.07 | +1.0% | 648.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |